Stem Cell Therapeutics in Modern Era
Stem-cell medical care is that the use of stem cells to cure or forestall a sickness or condition. Bone is that the most generally used stem-cell medical care, however some therapies derived from duct blood also are in use. Analysis is on the thanks to develop numerous sources for stem cells, and to use stem-cell treatments for neurodegenerative diseases and conditions like polygenic disease, cardiopathy and different conditions. Stem-cell medical care became arguable following developments like the power of scientists to isolate and culture embryonic stem cells, to make somatic cells victimisation cell nuclear transfer and their techniques to make evoked pluripotent stem cell. This disceptation is expounded to abortion politics and conjointly to human biological research. And also, efforts to promote treatments supported transplant of keep duct blood are arguable.
Novel somatic cell Technologies
Efficient cell/dna Delivery and microencapsulation techniques
Cancer medical care
Rheumatoid arthritis and neural structure injury
Parkinson’s sickness
Severe burns and polygenic disease
Imaging technologies, single molecule imaging, and super-resolution
Proteomic and genomic strategies
Normal and pathological organs and medical specialty
Related Conference of Stem Cell Therapeutics in Modern Era
18th International Conference on Human Genomics and Genomic Medicine
21th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
16th International Conference on Human Genetics and Genetic Diseases
19th International Conference on Genomics & Pharmacogenomics
Stem Cell Therapeutics in Modern Era Conference Speakers
Recommended Sessions
- Immunotherapy
- Biomaterials and Biomechanics
- Biomedical Engineering
- Cancer Cell Biology
- Cancer Gene Therapy
- Cell Medical Care Bioprocessing
- Cell Therapy
- Clinical and Translation Research
- Clinical applications of Stem Cells
- Gene Therapy
- Genetic Medicine
- Medical and Nano Biotechnology
- Stem Cell Therapeutics in Modern Era
- Stem Cells Growth and Regeneration
Related Journals
Are you interested in
- Achieving efficient delivery and editing - CRISPR 2025 (Italy)
- Artificial Intelligence and Computational Biology in Regenerative Medicine - Stemgen 2026 (France)
- Bioinformatics - HUMAN GENOME 2025 (France)
- Biomaterials and Nanotechnology in Regenerative Medicine - Stemgen 2026 (France)
- Cancer and stem cells - CRISPR 2025 (Italy)
- Cancer Genomics - HUMAN GENOME 2025 (France)
- Cancer Stem Cells and Oncology - Stemgen 2026 (France)
- Cardiovascular Regeneration - Stemgen 2026 (France)
- Clinical Trials and Translational Stem Cell Research - Stemgen 2026 (France)
- Cognitive Computing - HUMAN GENOME 2025 (France)
- Computational Biology - HUMAN GENOME 2025 (France)
- CRISPR technologies and society - CRISPR 2025 (Italy)
- CRISPR technologies beyond genome editing and gene regulation - CRISPR 2025 (Italy)
- Drug Detection & Development in Bioinformatics - HUMAN GENOME 2025 (France)
- Emergency Medicine - HUMAN GENOME 2025 (France)
- Epigenetics Biomarkers - HUMAN GENOME 2025 (France)
- Ethical, Legal, and Social Implications in Stem Cell Research - Stemgen 2026 (France)
- Future Trends: Organoids, Bioengineering, and Next-Generation Therapies - Stemgen 2026 (France)
- Gene Editing and CRISPR Technologies - Stemgen 2026 (France)
- Genetically Modified Organisms - HUMAN GENOME 2025 (France)
- Genome editing and gene regulation in human health - CRISPR 2025 (Italy)
- Genome editing and gene regulation in industrial bacterial biotechnology - CRISPR 2025 (Italy)
- Genome editing and gene regulation in industrial eukaryotic biotechnology - CRISPR 2025 (Italy)
- Genome Editing Methods and Novel Tools - CRISPR 2025 (Italy)
- Genome Mapping - HUMAN GENOME 2025 (France)
- Genomic Approach to Drug Discovery - HUMAN GENOME 2025 (France)
- Genomic Information in Medicine - HUMAN GENOME 2025 (France)
- Genomic Vaccination - HUMAN GENOME 2025 (France)
- Genomics - HUMAN GENOME 2025 (France)
- Horizons of CRISPR biology - CRISPR 2025 (Italy)
- Human Gene Therapy - HUMAN GENOME 2025 (France)
- Human Genetics - HUMAN GENOME 2025 (France)
- Induced Pluripotent Stem Cells (iPSCs) and Reprogramming - Stemgen 2026 (France)
- Infectious Diseases - HUMAN GENOME 2025 (France)
- Medicine Genomics - HUMAN GENOME 2025 (France)
- Mesenchymal Stem Cells (MSCs) in Therapy - Stemgen 2026 (France)
- Personalized Medicine - HUMAN GENOME 2025 (France)
- Pharma Genomics & Pharma Informatics - HUMAN GENOME 2025 (France)
- Plant and Animal Biotechnology - CRISPR 2025 (Italy)
- Preimplantation Genetic Diagnosis - HUMAN GENOME 2025 (France)
- Regenerative Dentistry and Craniofacial Applications - Stemgen 2026 (France)
- Regenerative Medicine and Tissue Engineering - Stemgen 2026 (France)
- Stem Cell Banking and Cryopreservation - Stemgen 2026 (France)
- Stem Cell Biology and Cellular Mechanisms - Stemgen 2026 (France)
- Stem Cells in Neurological and Neurodegenerative Disorders - Stemgen 2026 (France)
- Structural Biology and Bioinformatics - CRISPR 2025 (Italy)
- Therapeutic Genome Editing - CRISPR 2025 (Italy)